AKKUŞ, G. Et Al. 2022. CDKN1B mutation analyses and biochemical characteristics in patients with symptomatic or asymptomatic primary hyperparathyroidism. CUKUROVA MEDICAL JOURNAL , vol.47, no.2 , 852-860.

AKKUŞ, G., Coskun, N. S. S., Karagun, B., & TETİKER, B. T., (2022). CDKN1B mutation analyses and biochemical characteristics in patients with symptomatic or asymptomatic primary hyperparathyroidism. CUKUROVA MEDICAL JOURNAL , vol.47, no.2, 852-860.

AKKUŞ, GAMZE Et Al. "CDKN1B mutation analyses and biochemical characteristics in patients with symptomatic or asymptomatic primary hyperparathyroidism," CUKUROVA MEDICAL JOURNAL , vol.47, no.2, 852-860, 2022

AKKUŞ, GAMZE Et Al. "CDKN1B mutation analyses and biochemical characteristics in patients with symptomatic or asymptomatic primary hyperparathyroidism." CUKUROVA MEDICAL JOURNAL , vol.47, no.2, pp.852-860, 2022

AKKUŞ, G. Et Al. (2022) . "CDKN1B mutation analyses and biochemical characteristics in patients with symptomatic or asymptomatic primary hyperparathyroidism." CUKUROVA MEDICAL JOURNAL , vol.47, no.2, pp.852-860.

@article{article, author={GAMZE AKKUŞ Et Al. }, title={CDKN1B mutation analyses and biochemical characteristics in patients with symptomatic or asymptomatic primary hyperparathyroidism}, journal={CUKUROVA MEDICAL JOURNAL}, year=2022, pages={852-860} }